Hengkang Medical Group Co Ltd
SZSE:002219
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.69
3.19
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Hengkang Medical Group Co Ltd
Cash from Investing Activities
Hengkang Medical Group Co Ltd
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Hengkang Medical Group Co Ltd
SZSE:002219
|
Cash from Investing Activities
-ÂĄ333.3m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
2%
|
||
H
|
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
|
Cash from Investing Activities
-ÂĄ2.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Cash from Investing Activities
-ÂĄ3.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-22%
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Cash from Investing Activities
-ÂĄ551.2m
|
CAGR 3-Years
31%
|
CAGR 5-Years
31%
|
CAGR 10-Years
-12%
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Cash from Investing Activities
ÂĄ1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Cash from Investing Activities
-ÂĄ1B
|
CAGR 3-Years
-54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Hengkang Medical Group Co Ltd
Glance View
Hengkang Medical Group Co Ltd. stands as a testament to the burgeoning evolution of healthcare in China. Founded with a vision to modernize traditional healthcare systems, the company has woven an intricate network of hospitals and healthcare services across the country, tapping into the ever-growing demand for quality medical care. At the heart of Hengkang's operations is its commitment to providing comprehensive medical services—from outpatient and inpatient care to specialized treatments—all under one roof. This vertically integrated approach not only ensures seamless delivery of care but also drives efficiencies through economies of scale. By investing in advanced medical technologies and skilled professionals, Hengkang positions itself as a leader in the healthcare landscape, providing services that cater to diverse medical needs, thereby consistently drawing a steady stream of patients and insurance collaborations. What sets Hengkang apart is its keen focus on aligning healthcare delivery with digital transformation. The company leverages digital platforms to streamline its operations, enhance patient experiences, and optimize resource allocation. This digital shift plays a crucial role in its revenue model—Hengkang taps into data analytics to provide value-added services, optimize operational workflows, and predict healthcare trends, which not only improve patient outcomes but also drive profitability. Furthermore, its portfolio extends beyond clinical care; the group actively engages in partnering with biotech research initiatives and health management programs, broadening its reach and reinforcing its market position as an integrated healthcare service provider. This multifaceted strategy ensures Hengkang's resilience and adaptability in an ever-changing industry, catalyzing its growth and solidifying its reputation as a beacon of modern healthcare.
See Also
What is Hengkang Medical Group Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-333.3m
CNY
Based on the financial report for Sep 30, 2024, Hengkang Medical Group Co Ltd's Cash from Investing Activities amounts to -333.3m CNY.
What is Hengkang Medical Group Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
2%
The average annual Cash from Investing Activities growth rates for Hengkang Medical Group Co Ltd have been -21% over the past three years , -8% over the past five years , and 2% over the past ten years .